BETAMETHASONE DIPROPIONATE

Post-LOE

betamethasone dipropionate

PharmaIN

ANDATOPICALGEL, AUGMENTED

Approved

Dec 2003

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

BETAMETHASONE DIPROPIONATE (betamethasone dipropionate) by PharmaIN is clinical pharmacology like other topical corticosteroids, betamethasone dipropionate has anti-inflammatory, anti-pruritic, and vasoconstrictive properties. Approved for mild to moderate plaque psoriasis in patients 18 years of age, older, psoriasis. First approved in 2003.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Like other topical corticosteroids, betamethasone dipropionate has anti-inflammatory, anti-pruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by…

Indications (3)

mild to moderate plaque psoriasis in patients 18 years of age

Worked on BETAMETHASONE DIPROPIONATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (19)

NCT05882903Phase 2Recruiting

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Started Aug 2023

24 enrolled

Chronic Rhinosinusitis (Diagnosis)

NCT05811234N/ACompleted

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Started Jun 2023

291 enrolled

Plaque Psoriasis

NCT05220293Phase 1/2Terminated

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Started Feb 2022

2 enrolled

Chronic Rhinosinusitis (Diagnosis)

NCT03898583Phase 1Completed

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

Started Apr 2019

15 enrolled

Psoriasis Vulgaris

NCT03442244Phase 1Completed

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Started Jan 2018

20 enrolled

Psoriasis Vulgaris